Endocarditis
📧 Sign up to get email alerts when something new happens for Endocarditis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-03-31FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Eugia US LLC)
The FDA approved a generic vancomycin hydrochloride for injection under an original application from Eugia US LLC. This adds a generic IV op…
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Artificial Valve Endocarditis Reduction Trial [NA]
Clinical trial for an artificial valve addressing endocarditis in aortic and mitral valve disease; study terminated with results posted in 2…
-
CLINICAL_TRIALS research · 2015-05-13Clinical Trial Update: Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin [Phase 4]
A Phase 4 pharmacokinetics/pharmacodynamics study of vancomycin is described, sponsored by Zhejiang University, examining its PK/PD in blood…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Outcomes Following Medical or Surgical Management of Endocarditis
A completed clinical trial update reporting outcomes for endocarditis patients managed with medical therapy or surgical intervention.
-
FDA approval · 2012-04-09FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original ANDA for vancomycin hydrochloride from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., enabling a g…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-29Clinical Trial Update: Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections [Phase 4]
A Phase 4 trial evaluated diagnosing septicaemia in severe infections by detecting microbial DNA in blood, involving febrile neutropenia, en…
-
CLINICAL_TRIALS trial_result · 2011-12-06Clinical Trial Update: Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia [Phase 2]
Phase 2 study investigating higher doses of daptomycin and vancomycin for MRSA bacteremia/endocarditis was terminated with results posted in…
-
FDA approval · 2011-06-30FDA Approved: NAFCILLIN — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for Nafcillin sodium (NAFCILLIN SODIUM) as a generic injectable antibiotic from Fresenius Kabi USA, LL…
-
FDA approval · 2011-04-20FDA Approved: NAFCILLIN — Original Application (Athenex Pharmaceutical Division, LLC.)
FDA approves the original application for Nafcillin (nafcillin sodium) as a generic antibiotic from Athenex Pharmaceutical Division, LLC.
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections
Retrospective evaluation of the safety and efficacy of daptomycin in patients with serious Gram-positive infections, including bacteremia an…
-
FDA approval · 2008-12-30FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved the original application for vancomycin hydrochloride from Mylan Institutional LLC, marking the approval of a generic injectabl…
-
CLINICAL_TRIALS trial_result · 2007-10-23Clinical Trial Update: Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia
A completed clinical trial evaluating combination therapy with a fluoroquinolone for Staphylococcus aureus bacteremia.